NEW YORK (Reuters Health) – Drug-eluting stents can prevent leg amputations in patients with atherosclerosis and severe below-the-knee ischemia, according to a report in the April 13th Journal…
NEW YORK (Reuters Health) – Lithium did not delay the progression of amyotrophic lateral sclerosis (ALS) in a randomized placebo-controlled trial, the investigators reported online April 6 in…
NEW YORK (Reuters Health) – Ambulatory telemetry can provide lifesaving information that is unavailable with other modalities, new research suggests. More than 26,000 patients with routine clinical indications…
NEW YORK (Reuters Health) – Pooled data from multiple studies indicate that repetitive transcranial magnetic stimulation (rTMS) is useful for depression, auditory verbal hallucinations, and possibly for negative…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…
NEW YORK (Reuters Health) – Treatment with dutasteride reduces incident prostate cancers in men with high prostate specific antigen (PSA) levels, according to a report in The New…
NEW YORK (Reuters Health) – If asymptomatic lower pole renal calculi require intervention, percutaneous nephrolithotomy will provide a higher stone-free rate than shock wave lithotripsy, and with less…
NEW YORK (Reuters Health) – Once-a-week treatment with long-acting exenatide (Byetta) produces sustained glycemic control and weight loss in diabetics, a multicenter trial has shown. “This study confirms…
NEW YORK (Reuters Health) – Sertraline plus naltrexone is more effective than either agent alone in promoting abstinence in depressed alcohol-dependent patients, according to study findings in the…
NEW YORK (Reuters Health) – Percutaneous tibial nerve stimulation is an effective therapy for overactive bladder symptoms, according to a report in the April issue of The Journal…
